ANMCO position paper on vericiguat use in heart failure: from evidence to place in therapy

In the growing therapeutic armamentarium for heart failure (HF) management, vericiguat represents an innovative therapeutic option. The biological target of this drug is different from that of other drugs for HF. Indeed, vericiguat does not inhibit neuro-hormonal systems overactivated in HF or sodiu...

Descripción completa

Detalles Bibliográficos
Autores principales: Di Fusco, Stefania Angela, Alonzo, Alessandro, Aimo, Alberto, Matteucci, Andrea, Intravaia, Rita Cristina Myriam, Aquilani, Stefano, Cipriani, Manlio, De Luca, Leonardo, Navazio, Alessandro, Valente, Serafina, Gulizia, Michele Massimo, Gabrielli, Domenico, Oliva, Fabrizio, Colivicchi, Furio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10194817/
https://www.ncbi.nlm.nih.gov/pubmed/37213802
http://dx.doi.org/10.1093/eurheartjsupp/suad106

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10194817/
https://www.ncbi.nlm.nih.gov/pubmed/37213802
http://dx.doi.org/10.1093/eurheartjsupp/suad106

Ejemplares similares